All In Biotech

Drug Trial Radar · NCT00654576

Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia

Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With Schizophrenia:One-Year Follow up.

Last checked: Nov 19, 2026Latest source record: Apr 8, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,400 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,400

Planned (sponsor's estimate)

Start

Feb 2005

Primary completion

Dec 2007

Study completion Dec 2007

Sponsor

Lead sponsor
Central South UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Shanghai Mental Health Center; Sichuan University; Capital Medical University; Nanjing Medical University; Jiangxi Mental Hospital; Hunan Mental Hospital; Guangzhou Mental Hospital; Chongqing Metal Institute; Henan Mental Hospital
First posted
Apr 8, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Factorial
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 16 years, up to 50 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Antipsychotic alone is limit to improve the overall outcome of schizophrenia and has a high discontinue rate.To solve these problems, we provide practical and available psychosocial intervention. We hypothesize that there will be significant difference in the overall effectiveness between antipsychotic and antipsychotic combination with psychosocial intervention.

Conditions

  • Schizophrenia

Interventions

  • Chlorpromazine, Sulpiride, Clozapine, Olanzapine, Risperidone, Quetiapine, AripitrazoleDrug

    patient will receive one of the seven study drugs (Chlorpromazine, Sulpiride, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripitrazole) as the maintain treatment. the dose is flexible, is based on the study doctor's judgment.

  • psychosocial interventionBehavioral

    the psychosocial interventions include psychoeducaiton, family intervention, skill training, and cognitive-behavioral therapy.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. the time to discontinued treatment and the rate of relapse/rehospitalization

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Institute of Mental Health of The Second Xiangya Hospital, Central South University

    Changsha, Hunan, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.